Longmont’s Avista Pharma to be acquired
LONGMONT — Avista Pharma Solutions Inc., a pharmaceutical-ingredient manufacturing company with a major Longmont presence, has been acquired by Cambrex Corp. (NYSE: CBM). The firm has been acquired for $252 million.
Cambrex is based in East Rutherford, N.J., and is a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs).
Through the acquisition, Cambrex will enter the growing market for early stage molecule development and testing services. Avista offers services ranging from API and drug product development to standalone microbiology testing.
“We are excited to announce our acquisition of Avista,…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!